American Cancer Society Lung Cancer Screening Guidelines

被引:667
作者
Wender, Richard [1 ]
Fontham, Elizabeth T. H. [2 ]
Barrera, Ermilo, Jr. [3 ,4 ]
Colditz, Graham A. [5 ,6 ]
Church, Timothy R. [7 ]
Ettinger, David S. [8 ]
Etzioni, Ruth [9 ]
Flowers, Christopher R. [10 ]
Gazelle, G. Scott [11 ,12 ]
Kelsey, Douglas K. [13 ]
LaMonte, Samuel J. [14 ]
Michaelson, James S. [15 ,16 ]
Oeffinger, Kevin C. [17 ]
Shih, Ya-Chen Tina [18 ,19 ]
Sullivan, Daniel C. [20 ]
Travis, William [21 ]
Walter, Louise [22 ]
Wolf, Andrew M. D. [23 ]
Brawley, Otis W. [24 ]
Smith, Robert A. [25 ]
机构
[1] Thomas Jefferson Univ, Coll Med, Dept Family & Community Med, Philadelphia, PA 19107 USA
[2] Louisiana State Univ, Sch Publ Hlth, Hlth Sci Ctr, New Orleans, LA USA
[3] NorthShore Univ Hlth Syst, Dept Surg, Evanston, IL USA
[4] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA
[5] Washington Univ, Sch Med, Inst Publ Hlth, St Louis, MO USA
[6] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA
[7] Univ Minnesota, Sch Publ Hlth, Dept Environm Hlth Sci, Masonic Canc Ctr, Minneapolis, MN USA
[8] Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD USA
[9] Univ Washington, Sch Publ Hlth, Fred Hutchinson Canc Res Ctr, Hlth Serv, Seattle, WA 98195 USA
[10] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Ctr Comprehens Informat,Winship Canc Inst, Atlanta, GA USA
[11] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA
[12] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Cambridge, MA 02138 USA
[13] US Med Div Neurosci, Lilly Res Labs, Indianapolis, IN USA
[14] Louisiana State Univ, Sch Med, Dept Otolaryngol & Head & Neck Surg, Shreveport, LA USA
[15] Massachusetts Gen Hosp, Lab Quantitat Med, Cambridge, MA USA
[16] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA
[17] Mem Sloan Kettering Canc Ctr, Adult Long Term Follow Up Program, New York, NY 10021 USA
[18] Univ Chicago, Dept Med, Sect Hosp Med, Chicago, IL 60637 USA
[19] Univ Chicago, Program Econ Canc, Chicago, IL 60637 USA
[20] Duke Univ, Med Ctr, Dept Radiol, Chapel Hill, NC USA
[21] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
[22] Univ Calif San Francisco, Dept Med, Div Geriatr, Geriatr Res Program, San Francisco, CA USA
[23] Univ Virginia Hlth Syst, Dept Med, Charlottesville, VA USA
[24] Amer Canc Soc, Atlanta, GA 30303 USA
[25] Amer Canc Soc, Canc Control Sci Dept, Atlanta, GA 30303 USA
关键词
humans; lung neoplasms; mortality; radiography; radiation dosage; randomized controlled trials as topic; risk; risk reduction behavior; x-ray; computed tomography; adverse effects; lung cancer screening; COMPUTED-TOMOGRAPHY SCANS; SPIRAL CT; MORTALITY; TRIAL; SMOKING; RISK; DESIGN; ASSOCIATION; RECRUITMENT; PROGRAM;
D O I
10.3322/caac.21172
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Findings from the National Cancer Institute's National Lung Screening Trial established that lung cancer mortality in specific high-risk groups can be reduced by annual screening with low-dose computed tomography. These findings indicate that the adoption of lung cancer screening could save many lives. Based on the results of the National Lung Screening Trial, the American Cancer Society is issuing an initial guideline for lung cancer screening. This guideline recommends that clinicians with access to high-volume, high-quality lung cancer screening and treatment centers should initiate a discussion about screening with apparently healthy patients aged 55 years to 74 years who have at least a 30-pack-year smoking history and who currently smoke or have quit within the past 15 years. A process of informed and shared decision-making with a clinician related to the potential benefits, limitations, and harms associated with screening for lung cancer with low-dose computed tomography should occur before any decision is made to initiate lung cancer screening. Smoking cessation counseling remains a high priority for clinical attention in discussions with current smokers, who should be informed of their continuing risk of lung cancer. Screening should not be viewed as an alternative to smoking cessation. CA Cancer J Clin 2013;63:106-117. (C) 2013 American Cancer Society.
引用
收藏
页码:107 / 117
页数:11
相关论文
共 59 条
[1]
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening [J].
Aberle, Denise R. ;
Adams, Amanda M. ;
Berg, Christine D. ;
Black, William C. ;
Clapp, Jonathan D. ;
Fagerstrom, Richard M. ;
Gareen, Ilana F. ;
Gatsonis, Constantine ;
Marcus, Pamela M. ;
Sicks, JoRean D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (05) :395-409
[2]
American College of Radiology Imaging Network, 2004, 6654 ACRIN, P1
[3]
American Lung Association, 2012, GUID LUNG CANC SCREE
[4]
[Anonymous], STAT NAT LUNG SCREEN
[5]
[Anonymous], 2012, Cancer Trends Progress Report-2011/2012 Update
[6]
[Anonymous], 2019, WHO REPORT GLOBAL TO
[7]
Benchmarking lung cancer mortality rates in current and former smokers [J].
Bach, PB ;
Elkin, EB ;
Pastorino, U ;
Kattan, MA ;
Mushlin, AI ;
Begg, CB ;
Parkin, DM .
CHEST, 2004, 126 (06) :1742-1749
[8]
Benefits and Harms of CT Screening for Lung Cancer A Systematic Review [J].
Bach, Peter B. ;
Mirkin, Joshua N. ;
Oliver, Thomas K. ;
Azzoli, Christopher G. ;
Berry, Donald A. ;
Brawley, Otis W. ;
Byers, Tim ;
Colditz, Graham A. ;
Gould, Michael K. ;
Jett, James R. ;
Sabichi, Anita L. ;
Smith-Bindman, Rebecca ;
Wood, Douglas E. ;
Qaseem, Amir ;
Detterbeck, Frank C. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (22) :2418-2429
[9]
Lung cancer rates in men and women with comparable histories of smoking [J].
Bain, C ;
Feskanich, D ;
Speizer, FE ;
Thun, M ;
Hertzmark, E ;
Rosner, BA ;
Colditz, GA .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (11) :826-834
[10]
Berlin NI, 2000, CANCER, V89, P2349, DOI 10.1002/1097-0142(20001201)89:11+<2349::AID-CNCR6>3.3.CO